ArticleFrontiers in oncology2023

Sec61 blockade therapy overrides resistance to proteasome inhibitors and immunomodulatory drugs in multiple myeloma.

Antoine Domenger et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.